# The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-effects-of-the-cardiac-myosin-activator-omecamtiv-mecarbil-on-cardiac/

## Facts

| Field | Value |
| --- | --- |
| Author Names | John G.F. Cleland,John R. Teerlink,Roxy Senior,Evgeny M. Nifontov,John Murray,Chim C. Lang,Vitaly A. Tsyrlin,Barry Greenberg,Jamil Mayet,Dárrel P. Francis,Tamaz Shaburishvili,Mark Monaghan,Mitchell Saltzberg,Ludwig Neyses,Scott M. Wasserman,Jacqueline H. Lee,Khalil G. Saikali,Cyril P. Clarke,Jonathan H. Goldman,Andrew A. Wolff,Fady I. Malik |
| Citations | 332 |
| DOI | 10.1016/s0140-6736(11)61126-4 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1984848816 |
| PMID | 21856481 |
| Type | article |
| Year | 2011 |

## Paper authors

- [John G.F. Cleland](https://scholariq.org/researchers/john-g-f-cleland/)
- [John R. Teerlink](https://scholariq.org/researchers/john-r-teerlink/)
- [Roxy Senior](https://scholariq.org/researchers/roxy-senior/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

## Paper topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiomyopathy and Myosin Studies](https://scholariq.org/topics/cardiomyopathy-and-myosin-studies/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.